<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for North Hardwick Bolsover PCN</h1>
        This is some intro text.

        <h2>Prescribing where North Hardwick Bolsover PCN is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0301011E0&amp;denomIds=3.1.1&amp;selectedTab=summary">Formoterol fumarate</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>402</td>
      <td>Selective beta(2)-agonists</td>
      <td>14469</td>
      <td>0.03</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.63</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0301011E0AAAAAA&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Formoterol 12microgram inhalation pdr caps with device : 3</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0301011E0AAABAB&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Formoterol 6micrograms/dose dry powder inhaler : 3</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0301011E0AAACAC&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Formoterol 12micrograms/dose dry powder inhaler : 2</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0301011E0AAADAD&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Formoterol 12micrograms/dose inhaler CFC free : 96</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0301011E0BCABAC&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Oxis 12 Turbohaler : 2</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0301011E0BDAAAD&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Atimos Modulite 12micrograms/dose inhaler : 12</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0301011E0BEAAAC&amp;denomIds=3.1.1&amp;selectedTab=summary" target="_blank">Formoterol Easyhaler 12micrograms/dose dry powder inhaler : 284</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=1306010C0&amp;denomIds=13.6.1&amp;selectedTab=summary">Benzoyl peroxide</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>172</td>
      <td>Topical preparations for acne</td>
      <td>565</td>
      <td>0.30</td>
      <td>0.08</td>
      <td>0.04</td>
      <td>5.27</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=1306010C0AAABAB&amp;denomIds=13.6.1&amp;selectedTab=summary" target="_blank">Benzoyl peroxide 5% gel : 109</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=1306010C0BUAAAB&amp;denomIds=13.6.1&amp;selectedTab=summary" target="_blank">Acnecide 5% gel : 58</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=1306010C0BUACAB&amp;denomIds=13.6.1&amp;selectedTab=summary" target="_blank">Acnecide Wash 5% gel : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0908010T0&amp;denomIds=9.8.1&amp;selectedTab=summary">Betaine anhydrous</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Drugs used in metabolic disorders</td>
      <td>4</td>
      <td>1.00</td>
      <td>0.05</td>
      <td>0.20</td>
      <td>4.72</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0908010T0AAACAC&amp;denomIds=9.8.1&amp;selectedTab=summary" target="_blank">Betaine oral powder : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0202040U0&amp;denomIds=2.2.4&amp;selectedTab=summary">Triamterene with loop diuretics</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>10</td>
      <td>Potassium sparing diuretics and compounds</td>
      <td>60</td>
      <td>0.17</td>
      <td>0.01</td>
      <td>0.03</td>
      <td>4.56</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0202040U0AAAAAA&amp;denomIds=2.2.4&amp;selectedTab=summary" target="_blank">Triamterene 50mg / Furosemide 40mg tablets : 10</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0301020I0&amp;denomIds=3.1.2&amp;selectedTab=summary">Ipratropium bromide</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>665</td>
      <td>Antimuscarinic bronchodilators</td>
      <td>3369</td>
      <td>0.20</td>
      <td>0.07</td>
      <td>0.03</td>
      <td>3.94</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0301020I0AAACAC&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Ipratropium bromide 500micrograms/2ml neb liq ud vials : 36</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0301020I0AAAFAF&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Ipratropium bromide 250micrograms/1ml neb liq ud vials : 9</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0301020I0AAANAN&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Ipratropium bromide 20micrograms/dose inhaler CFC free : 548</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0301020I0BBACAC&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Atrovent 500micrograms/2ml nebuliser liquid UDVs : 5</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0301020I0BBAJAN&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Atrovent 20micrograms/dose inhaler CFC free : 67</a></div></td></tr></tbody></table>

        <h2>Prescribing where North Hardwick Bolsover PCN is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0202010P0&amp;denomIds=2.2.1&amp;selectedTab=summary">Indapamide</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>705</td>
      <td>Thiazides and related diuretics</td>
      <td>8095</td>
      <td>0.09</td>
      <td>0.42</td>
      <td>0.10</td>
      <td>-3.28</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0202010P0AAAAAA&amp;denomIds=2.2.1&amp;selectedTab=summary" target="_blank">Indapamide 2.5mg tablets : 520</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0202010P0AAADAD&amp;denomIds=2.2.1&amp;selectedTab=summary" target="_blank">Indapamide 1.5mg modified-release tablets : 185</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0501021L0&amp;denomIds=5.1.2&amp;selectedTab=summary">Cefalexin</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>245</td>
      <td>Cephalosporins</td>
      <td>316</td>
      <td>0.78</td>
      <td>0.96</td>
      <td>0.06</td>
      <td>-3.23</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAGiklEQVR4nO3dacgVVRzH8e95NLc2C618kQ5EFqEI2aJpUlESDJUQkVBJJJTQAtWLRiRaCJ0SKqgICqKFiooiiynMhZReqLT3ZKAZYwuZubQSWnp6cca4Xe59vMvMneeZ8/vAMN7F+z9z5/6eM3fmzFxjrUVE/NBXdgNEpHcUeBGPKPAiHlHgRTyiwIt4RIEX8YgCL+IRBV7EIwq8iEcUeBGPKPBVYIzGR0tLhpfdABFxgigZCVwIXA6cAixP43B1njWMTp6pAGMs1pqymyGdC6JkCrAC+Cib7wDuAfYDt6Zx+FUedRT4KlDgh7QgSqYDrwHXp3G4vuZ+A1wBPAick8bhr93WUuCrQIEfsoIomQG8BMxP43BTk+csBqYA16Zx2FVgtdNOpCRBlEwAXgSubBb2zEPABOC6bmsq8CIlCKJkOPAycH8ah58M9Nw0Dg/gwn5ft3UVeJFy3AtsS+PwuVaenMbhD0DcbVEdlhPpsSBK5gKXATPb/K/PdltbO+2qQDvthowgSsYBG4HL0jjc3Ov62qQX6ZHsMNvTwCNlhB0UeJFeWgiMAp4oqwHapK8CbdIPekGUnA68C8xM43BHWe1QDy9SsCBKxgCvAIvKDDso8CK98BjwdhqHK8tuiA7LiRQoiJIFuDPfbiq7LaDAixQmiJJZwN3AnDQO/ym7PaDAixQiiJLJwAvAvDQOfyy7PYfoO7xIzoIoGQ+8hdtJ93nZ7amlwIvkKDsDbg2wLI3D98puTz0FXiQnQZRMAtbiwt7SSTG9psCL5CCIkmnAKiBK4/DlstvTjAIv0qXs0NsbwMI0DleU3Z6BaC+9SIeCKDkKWI67/NTswbQ3vhn18CIdCKLkEuBjYDdw0VAIO6iHF2lLECUTgaXAacBVaRx+VnKT2qLAi7QgiJLjgLuAq4FluEtKD4rRc+1Q4EUGEETJScDtwHzgGWBqGod/lNuqzinwIg0EUXI2cDNwAfAkLui/ldqoHOgCGFWgC2DkIoiSE3A9+QLcTzw9DryexuG+UhuWI/Xw4rVsKOwVwDzcjrhXcd/P+0ttWEHUw1eBeviWBVEyFpgBXARcAozGnejyJrAx+9GHylLgq0CBbyiIkhG4QTHnZtMM3FbtJtyY99VpHKalNbAECnwVeB747GebJuHCPQWYms3HAptx14HfCGxK43BnWe0cDBT4KvAg8EGU9AEnA6fWTJOz+VHAduBLoB/4Auj3PdyNKPBVMIQDn/04w7HAOGB8Np+AC/fEmvkY4Htga820BdiaxuEvvW/50KTAV0ELgc96yBHZNLJuqr9vRM38CNz33uE1/+5kPgI4EtcbH5qPBgzwK7AL+Dmb/4Trsb8DvgW+S+Pw947fH/lPV4flgii5BXcCTv1kmtxXNNPi1Fd3O8/6jd6PZtOwLp83HDgiBYIo2cL/w1n7l9wAB3HHlvfVzPcd5vZ+4G/gnwbzfcAfdfc1et6h+f7s+X/WzP9K4/Bgu2+ydMFa2/UE3JjH6/hcq8rLpvdx8NTL6/TYG3N6HZ9r9bpeVWv1ut6QWjadDy/iEQVexCN5Bf6pnF7H51q9rlfVWr2uN6SWTYflRDyiTXoRj7R1HN4YMwc4D9hprX3GGHM+MBPYAOwArgH2WmsfzaNxh6l3PHAWsNZau7aAWvOAM3CDQ1bVPtZtrRbq7cb9MV5vrf2wgFoLgaOzh98hx/V2mFopOa6zJvVuwI2h344bYlvkstXWOkC+n8cLgEXW2vnZ7YXAicA63LiMjj6P7fbwM621MW4IJMDlwF+4QR0h8ABuhFZeBqr3J25Qx6giallr3wS2Aa80aEfR9fbgRqbldb2C+vYPw314dpL/ehuoVt7rrFG9idbah4FLKX7ZamvlumzW2veBT2vuGmetXQrMbtCOlrUb+Pov/MdYax8D5rZbuNt61tpV1tr7gDMLqgUw1Vrb3+SxwupZa5/PVujFBdXqs9Yuxv1ued6a1ipgnTWqt8YYcxtuuG7emtYqaNma1e7489huD7LBGHMXsMcYMx1YaYy5A7dJ8wGwBNjbaWPaqWeMmY273lheK7a+1je4nrb2sTzPvmpazxgT4jYPvy6o1hhjzJ24MevryHe9Na1VwDprVK8P18uuwK2vIpftv1p5L5sxZhowyxizBHge2GWMWQysB4Z1+nnUXnoRj2gvvYhHFHgRjyjwIh5R4EU8osCLeESBF/GIAi/iEQVexCMKvIhHFHgRjyjwIh75F/nfa6n9ltkZAAAAAElFTkSuQmCC"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0501021L0AAAAAA&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg capsules : 79</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0501021L0AAABAB&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 500mg capsules : 94</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0501021L0AAACAC&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 125mg/5ml oral suspension : 12</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0501021L0AAADAD&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg/5ml oral suspension : 13</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0501021L0AAAGAG&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg tablets : 42</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0501021L0AAAHAH&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 500mg tablets : 2</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0501021L0AAANAN&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 125mg/5ml oral suspension sugar free : 2</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=0501021L0AAAPAP&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Cefalexin 250mg/5ml oral suspension sugar free : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=1306010Y0&amp;denomIds=13.6.1&amp;selectedTab=summary">Benzoyl peroxide and clindamycin phosphate</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>110</td>
      <td>Topical preparations for acne</td>
      <td>565</td>
      <td>0.19</td>
      <td>0.37</td>
      <td>0.08</td>
      <td>-2.30</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=1306010Y0AAAAAA&amp;denomIds=13.6.1&amp;selectedTab=summary" target="_blank">Benzoyl peroxide 5% / Clindamycin 1% gel : 11</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=1306010Y0AAABAB&amp;denomIds=13.6.1&amp;selectedTab=summary" target="_blank">Benzoyl peroxide 3% / Clindamycin 1% gel : 77</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=1306010Y0BBAAAA&amp;denomIds=13.6.1&amp;selectedTab=summary" target="_blank">Duac Once Daily gel (5% and 1%) : 5</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=1306010Y0BBABAB&amp;denomIds=13.6.1&amp;selectedTab=summary" target="_blank">Duac Once Daily gel (3% and 1%) : 17</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=1306010Z0&amp;denomIds=13.6.1&amp;selectedTab=summary">Adapalene and benzoyl peroxide</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>9</td>
      <td>Topical preparations for acne</td>
      <td>565</td>
      <td>0.02</td>
      <td>0.16</td>
      <td>0.07</td>
      <td>-2.14</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=1306010Z0AAAAAA&amp;denomIds=13.6.1&amp;selectedTab=summary" target="_blank">Adapalene 0.1% / Benzoyl peroxide 2.5% gel : 9</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=1305030C0&amp;denomIds=13.5.3&amp;selectedTab=summary">Tacrolimus</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>20</td>
      <td>Drugs affecting the immune response</td>
      <td>35</td>
      <td>0.57</td>
      <td>0.80</td>
      <td>0.11</td>
      <td>-2.05</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=1305030C0AAAAAA&amp;denomIds=13.5.3&amp;selectedTab=summary" target="_blank">Tacrolimus 0.1% ointment : 12</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=1305030C0AAACAC&amp;denomIds=13.5.3&amp;selectedTab=summary" target="_blank">Tacrolimus 0.03% ointment : 4</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U05048&amp;numIds=1305030C0BBAAAA&amp;denomIds=13.5.3&amp;selectedTab=summary" target="_blank">Protopic 0.1% ointment : 4</a></div></td></tr></tbody></table>
        <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
        <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
    </div>

</body>

</html>